News About: Pharm. Industry
Zuellig Korea's tighter margin policy hits associate wholesalers
Zullig Korea's associate is facing a falling sales margin as the company are tightening sales its incentive criteria through a revised agreement.
Under the revised contract, Zuellig will provide associate wholesale...
SK Chemicals gears up for major expansion
SK Chemicals made its merger and acquisition (M&A) deal with Dongshin Pharm, an affiliated company, on August 9 for more expansion toward global advancement of its life science unit.
It is the first step toward SK ...
Drug wholesalers eye elderly care hospitals
A number of drug wholesalers are expanding their presence in recuperation centers as an emerging lucrative market.
Many wholesalers are vying to concentrate on recuperation hospitals because they cannot survive wit...
Online booking system is available for treatment and consultation
Both patients and medical representatives (MRs) can make their online bookings over the medical institutions using a new system, which has been developed by Medimet Co.
The company said this system enables health p...
Health ministry to cover 10,000 insured medicines only
The government plans to ask the national health insurance to cover only 10,000 conventional drugs by phase to reduce snowballing medication costs.
Earlier, the Ministry of Health and Welfare unveiled a set of measu...
KPMA calls for more rational approach to new drug pricing policy
The so-called positive list system reinforces the government's rash approach to shaping policies, according to the Korea Pharmaceutical Manufacturers Association (KPMA).
The KPMA said the ministry will have to over...
Iressa price issue: a signal for drug price slashing policy?
The price down of Iressa, a lung cancer drug, is now on a hot dispute among the MOHW, the civil health/medical groups and AZ company where is claiming that its price reduction has lack of justification.
AZ won the ...
Medium-sized drug makers go for duel with multinational giant
Competition is about to heat up in the Korean antihypertensive market dominated by Pfizer Korea's Norvasc (amlodipine besylate) as a growing number of medium-sized pharmaceutical firms are ready to enter the local mar...
Exports of pharmaceutical bulk products grew 0.29% in first half
Despite increased competition from China and other emerging economies, the nation's first-half outbound shipment for pharmaceutical raw materials edged up 0.29 percent to $235 million for the first time after fi...
Sehwa Pharm names new vice president
Sewha Pharm, a leading wholesaler in Pusan, appointed Lee Eun-bo as its new executive vice president as of August 2, to upgrade the detailing capacity of 30 salespersons to meet the needs of pharmaceutical firms.
T...
